One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy

Clinical trial NCT06809491 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06809491
Sponsor: Central Hospital, Nancy, France
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Melanoma, Skin Adjuvant Treatment

Start date: 2025-01-23
Primary completion: 2025-01-23
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.